Document is current
Any future updates will be listed below
-
Authors
Zhang, Yu
Ren, Shuhong
Yu, Jing
Xu, Shiqi
Zhang, Yujuan
Zhang, Jinyuan
Li, Xuechun
Shao, Jianfang
Lu, Lijuan
Gao, Fei
Tian, Jian
-
Funding
Funding for this research was provided by:
the construction of an individualized medication model for epilepsy in children based on artificial intelligence technology (20232035)
- License Information
-
More Information
Article History
Received: 27 October 2025
Accepted: 15 January 2026
First Online: 25 March 2026
Declarations
:
: The authors declare the following financial interests/personal relationships, which may be considered potential competing interests: methodological guidance and data analysis were provided by Beijing Medicinovo Technology Co., Ltd. and Dalian Medicinovo Technology Co., Ltd.The authors declare the following financial interests/personal relationships, which may be considered potential competing interests: methodological guidance and data analysis were provided by Beijing Medicinovo Technology Co., Ltd. and Dalian Medicinovo Technology Co., Ltd.
: The study was conducted in accordance with the Helsinki Declaration of 1964 and approved by the ethics committee of Baoding Hospital, Beijing Children’s Hospital, affiliated with the Capital Medical University (No.2025–64).
: Written informed consent for participation was not provided by the participant’s legal guardians/next of kin, because study data have been fully de-identified, and confidential information of patients has been deleted, in accordance with the CIOMS/WHO International Ethical Guidelines for Health-related Research Involving Humans (2016), and the study was deemed exempt from informed consent by study participants.
: Not applicable
: informed consent from the patients’ legal guardians was not required because all data were de-identified and anonymized in line with the CIOMS/WHO International Ethical Guidelines for Health-related Research Involving Humans (2016).
